<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" xml:lang="en" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Hernia</journal-id><journal-id journal-id-type="iso-abbrev">Hernia</journal-id><journal-id journal-id-type="pmc-domain-id">365</journal-id><journal-id journal-id-type="pmc-domain">springeropen</journal-id><journal-title-group><journal-title>Hernia</journal-title></journal-title-group><issn pub-type="ppub">1265-4906</issn><issn pub-type="epub">1248-9204</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>Springer</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC11249614</article-id><article-id pub-id-type="pmcid-ver">PMC11249614.1</article-id><article-id pub-id-type="pmcaid">11249614</article-id><article-id pub-id-type="pmcaiid">11249614</article-id><article-id pub-id-type="pmid">38386125</article-id><article-id pub-id-type="doi">10.1007/s10029-024-02976-3</article-id><article-id pub-id-type="publisher-id">2976</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Cannabis smoking and abdominal wall reconstruction outcomes: a propensity score-matched analysis</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0001-7072-1944</contrib-id><name name-style="western"><surname>Maskal</surname><given-names initials="S">S.</given-names></name><address><email>Maskals2@ccf.org</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Foreman</surname><given-names initials="JM">J. M.</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Ellis</surname><given-names initials="RC">R. C.</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Phillips</surname><given-names initials="S">S.</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Messer</surname><given-names initials="N">N.</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Melland-Smith</surname><given-names initials="M">M.</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Beffa</surname><given-names initials="LRA">L. R. A.</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Petro</surname><given-names initials="CC">C. C.</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Prabhu</surname><given-names initials="AS">A. S.</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Rosen</surname><given-names initials="MJ">M. J.</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Miller</surname><given-names initials="BT">B. T.</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/03xjacd83</institution-id><institution-id institution-id-type="GRID">grid.239578.2</institution-id><institution-id institution-id-type="ISNI">0000 0001 0675 4725</institution-id><institution>General Surgery, </institution><institution>Cleveland Clinic, </institution></institution-wrap>2049 E 100th St, Desk A-100, Cleveland, OH 44106 USA </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/05dq2gs74</institution-id><institution-id institution-id-type="GRID">grid.412807.8</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 9916</institution-id><institution>Department of Biostatistics, </institution><institution>Vanderbilt University Medical Center, </institution></institution-wrap>Nashville, TN USA </aff></contrib-group><pub-date pub-type="epub"><day>22</day><month>2</month><year>2024</year></pub-date><pub-date pub-type="ppub"><year>2024</year></pub-date><volume>28</volume><issue>3</issue><issue-id pub-id-type="pmc-issue-id">466794</issue-id><fpage>847</fpage><lpage>855</lpage><history><date date-type="received"><day>19</day><month>10</month><year>2023</year></date><date date-type="accepted"><day>25</day><month>1</month><year>2024</year></date></history><pub-history><event event-type="pmc-release"><date><day>22</day><month>02</month><year>2024</year></date></event><event event-type="pmc-live"><date><day>17</day><month>07</month><year>2024</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-07-17 10:25:15.587"><day>17</day><month>07</month><year>2024</year></date></event></pub-history><permissions><copyright-statement>&#169; The Author(s) 2024</copyright-statement><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="10029_2024_Article_2976.pdf"/><abstract id="Abs1"><sec><title>Purpose</title><p id="Par1">Despite increasing use of cannabis, literature on perioperative effects is lagging. We compared active cannabis-smokers versus non-smokers and postoperative wound morbidity and reoperations following open abdominal wall reconstruction (AWR).</p></sec><sec><title>Methods</title><p id="Par2">Patients who underwent open, clean, AWR with transversus abdominis release and retromuscular synthetic mesh placement at our institution between January 2014 and May 2022 were identified using the Abdominal Core Health Quality Collaborative database. Active cannabis-smokers were 1:3 propensity matched to non-smokers based on demographics and comorbidities. Wound complications, 30&#160;day morbidity, pain (PROMIS 3a-Pain Intensity), and hernia-specific quality of life (HerQles) were compared.</p></sec><sec><title>Results</title><p id="Par3">Seventy-two cannabis-smokers were matched to 216 non-smokers. SSO (18% vs 17% <italic toggle="yes">p</italic>&#8201;=&#8201;0.86), SSI (11.1% vs 9.3%, <italic toggle="yes">p</italic>&#8201;=&#8201;0.65), SSOPI (12% vs 12%, <italic toggle="yes">p</italic>&#8201;=&#8201;0.92), and all postoperative complications (46% vs 43%, <italic toggle="yes">p</italic>&#8201;=&#8201;0.63) were similar between cannabis-smokers and non-smokers. Reoperations were more common in the cannabis-smoker group (8.3% vs 2.8%, <italic toggle="yes">p</italic>&#8201;=&#8201;0.041), driven by major wound complications (6.9% vs 3.2%, <italic toggle="yes">p</italic>&#8201;=&#8201;0.004). No mesh excisions occurred. HerQles scores were similar at baseline (22 [11, 41] vs 35 [14, 55], <italic toggle="yes">p</italic>&#8201;=&#8201;0.06), and were worse for cannabis-smokers compared to non-smokers at 30&#160;days (30 [12, 50] vs 38 [20, 67], <italic toggle="yes">p</italic>&#8201;=&#8201;0.032), but not significantly different at 1&#160;year postoperatively (72 [53, 90] vs 78 [57, 92], <italic toggle="yes">p</italic>&#8201;=&#8201;0.39). Pain scores were worse for cannabis-smokers compared to non-smokers at 30&#160;days postoperatively (52 [46, 58] vs 49 [44, 54], <italic toggle="yes">p</italic>&#8201;=&#8201;0.01), but there were no differences at 6&#160;months or 1&#160;year postoperatively (<italic toggle="yes">p</italic>&#8201;&gt;&#8201;0.05 for all).</p></sec><sec><title>Conclusion</title><p id="Par4">Cannabis smokers will likely experience similar complication rates after clean, open AWR, but should be counseled that despite similar wound complication rates, the severity of their wound complications may be greater than non-smokers.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Cannabis</kwd><kwd>Incisional hernia</kwd><kwd>Abdominal wall reconstruction</kwd><kwd>Wound complications</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#169; Springer-Verlag France SAS, part of Springer Nature 2024</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Introduction</title><p id="Par5">Cannabis use has been increasing in the United States, with an estimated 35.5&#160;million individuals aged 26 or older reportedly using cannabis as of 2020, but its impact on surgical outcomes is still under investigation [<xref ref-type="bibr" rid="CR1">1</xref>]. Cannabis has become more accessible with policy changes, with 23 states and the District of Columbia that have legalized marijuana for recreational use as of 2023 [<xref ref-type="bibr" rid="CR2">2</xref>]. Cannabinoid receptors are present in many tissues throughout the body and have been shown in animal models to play a role in inflammatory response [<xref ref-type="bibr" rid="CR3">3</xref>], intestinal motility [<xref ref-type="bibr" rid="CR4">4</xref>], and gastric secretion [<xref ref-type="bibr" rid="CR5">5</xref>], but whether or not there are deleterious consequences in surgical patients is not well known [<xref ref-type="bibr" rid="CR6">6</xref>].</p><p id="Par6">In the setting of growing accessibility and awareness of cannabis use, it is essential for surgeons to investigate the effects of cannabis on perioperative outcomes to determine whether it needs to be considered during surgical planning and informed consent. Open abdominal wall reconstruction is a major operation with potential for serious postoperative wound and medical complications that may be perpetuated by cannabis use. Given the paucity of data surrounding the effect of cannabis use in this setting, we aim to investigate if there is an association between cannabis use and postoperative wound morbidity or reoperations in patients undergoing clean abdominal wall reconstruction with mesh.</p></sec><sec id="Sec2"><title>Methods</title><p id="Par7">This retrospective review was conducted after obtaining approval under exempt status by our Institutional Review Board. Patients who underwent open, ventral hernia repair with transversus abdominis release and retromuscular synthetic mesh placement with CDC class I wounds at our institution between January 2014 and May 2022 were identified using the Abdominal Core Health Quality Collaborative (ACHQC) database. The ACHQC is a hernia-specific, prospectively collected, national database of voluntary surgeon-entered data, including patient characteristics, operative details, perioperative and long-term outcomes, as well as patient-reported outcomes [<xref ref-type="bibr" rid="CR7">7</xref>]. Additionally, retrospective chart review was used to identify patients meeting inclusion criteria as current cannabis-smokers and non-smokers. Keywords utilized to query the electronic medical record included: &#8220;marijuana&#8221;, &#8220;THC&#8221;, &#8220;cannabis&#8221;, &#8220;cannabinoid&#8221;, &#8220;weed&#8221;, &#8220;pot&#8221;, as well as the information input in the drug use section of the EMR (&#8220;drug use: yes/no&#8221;, &#8220;drug use frequency&#8221;, and any comments entered in the drug use section). Cannabis smokers were defined as reporting regular inhaled use at their preoperative visit. The ACHQC database was then queried for analysis based on our exposed and control categories.</p><p id="Par8">The primary outcome of interest was 30&#160;day wound morbidity which is defined as surgical site occurrences (SSO), surgical site infections (SSI), and surgical site occurrences requiring procedural intervention (SSOPI) [<xref ref-type="bibr" rid="CR8">8</xref>]. SSO encompasses wound cellulitis, seroma, wound dehiscence, or formation of an enterocutaneous fistula, and SSOPI indicates that a procedural intervention occurred. SSI includes any surgical infection [<xref ref-type="bibr" rid="CR8">8</xref>]. Secondary outcomes of interest included 30&#160;day all morbidity, readmissions, and reoperations. Patient-reported outcomes included pain as measured by NIH Patient-Reported Outcome Measurement Information System (PROMIS)-3a-Pain Intensity score and abdominal wall-specific quality of life as measured by the Hernia-Related Quality-of-Life (HerQLes) survey, both of which were available at baseline, 30&#160;days, 6&#160;months, and 1&#160;year postoperatively. HerQLes is a hernia-specific quality-of-life survey, which is a validated score from 0 to 100, with increasing scores indicating better quality of life and a defined minimal clinically important difference of 15.6 points [<xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR10">10</xref>]. Patient-Reported Outcomes Measurement Information System (PROMIS) 3a-Pain Intensity survey is a three question survey addressing pain over the preceding week, reported as converted T-scores of 30.7&#8211;71.8, with lower scores indicating less pain [<xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR12">12</xref>]. The HerQLes and PROMIS surveys are routinely collected at baseline, 30&#160;days, 6&#160;months, and 1&#160;year. Responses to the HerQLes and PROMIS surveys were compared using Wilcoxon rank sum tests. The Distressed Community Index (DCI) was used to compare the association of cannabis use with socioeconomic distress. The DCI is a score indexed to zip codes that was developed from US census data to describe the socioeconomic distress of a community based on seven indicators of prosperity: prevalence of high school diplomas, housing vacancies, poverty, unemployment, changes in employment, and business establishments, and the ratio of median income [<xref ref-type="bibr" rid="CR13">13</xref>]. DCI scores range from 0, indicating no distress, to 100, indicating high distress.</p><p id="Par9">Baseline characteristics were analyzed using simple descriptive and univariate statistics. Current cannabis-smokers were matched 1:3 to a group of non-smokers based on propensity scores. We estimated the propensity score with a logistic regression and included the following in the model: age, race, insurance status, body mass index (BMI), current tobacco smoker status, diabetes mellitus, chronic obstructive pulmonary disease (COPD), immunosuppressants use, inflammatory bowel disease (IBD), hepatic dysfunction, recurrent hernia, hernia width, and Ventral Hernia Working Group grade (VHWG). As retrospective, descriptive study, missing data were anticipated and were not addressed in the statistical analysis.</p></sec><sec id="Sec3"><title>Results</title><p id="Par10">We identified 1311 patients meeting inclusion criteria. Seventy-two cannabis-smokers were matched in a 1:3 ratio to 216 non-smokers. Prior to propensity score matching, the cannabis-smokers group included fewer white patients (83.3% vs 93.4%, <italic toggle="yes">p</italic>&#8201;=&#8201;0.001), younger age (54 [44, 60] vs 60 [52, 68], <italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.001), more patients from distressed communities (29% vs 15%, <italic toggle="yes">p</italic>&#8201;=&#8201;0.019), and higher rates of IBD (12.5% vs 5.4%, <italic toggle="yes">p</italic>&#8201;=&#8201;0.012), current smokers (12.5% vs. 5.2%), COPD (16.7% vs 8.7%, <italic toggle="yes">p</italic>&#8201;=&#8201;0.023), and hepatic dysfunction (4.2% vs 1.1%, <italic toggle="yes">p</italic>&#8201;=&#8201;0.019). After matching, all demographics (Table&#160;<xref rid="Tab1" ref-type="table">1</xref>) and operative details were similar (Fig.&#160;<xref rid="Fig1" ref-type="fig">1</xref>; Table&#160;<xref rid="Tab2" ref-type="table">2</xref>).<table-wrap id="Tab1" position="float" orientation="portrait"><label>Table&#160;1</label><caption><p> Demographics and comorbidities</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="1" rowspan="1"/><th align="left" colspan="1" rowspan="1">Cannabis smoker <italic toggle="yes">n</italic>&#8201;=&#8201;72</th><th align="left" colspan="1" rowspan="1">Non-smoker <italic toggle="yes">n</italic>&#8201;=&#8201;216</th><th align="left" colspan="1" rowspan="1"><italic toggle="yes">p</italic> value</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">Male</td><td char="(" align="char" colspan="1" rowspan="1">54% (39)</td><td char="(" align="char" colspan="1" rowspan="1">53% (114)</td><td char="." align="char" colspan="1" rowspan="1">0.84</td></tr><tr><td align="left" colspan="1" rowspan="1">White race</td><td char="(" align="char" colspan="1" rowspan="1">83% (60)</td><td char="(" align="char" colspan="1" rowspan="1">82% (178)</td><td char="." align="char" colspan="1" rowspan="1">0.86</td></tr><tr><td align="left" colspan="1" rowspan="1">Age, years, median (IQR)</td><td char="(" align="char" colspan="1" rowspan="1">54 (44, 60)</td><td char="(" align="char" colspan="1" rowspan="1">54 (45, 62)</td><td char="." align="char" colspan="1" rowspan="1">0.48</td></tr><tr><td align="left" colspan="1" rowspan="1">BMI, kg/m<sup>2</sup>, median (IQR)</td><td char="(" align="char" colspan="1" rowspan="1">33 (28, 36)</td><td char="(" align="char" colspan="1" rowspan="1">33 (29, 36)</td><td char="." align="char" colspan="1" rowspan="1">0.99</td></tr><tr><td align="left" colspan="1" rowspan="1">Current tobacco use</td><td char="(" align="char" colspan="1" rowspan="1">12% (9)</td><td char="(" align="char" colspan="1" rowspan="1">11% (23)</td><td char="." align="char" colspan="1" rowspan="1">0.67</td></tr><tr><td align="left" colspan="4" rowspan="1">Distressed community index</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Distressed</td><td char="(" align="char" colspan="1" rowspan="1">29% (21)</td><td char="(" align="char" colspan="1" rowspan="1">19% (39)</td><td char="." align="char" rowspan="5" colspan="1">0.25</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;At risk</td><td char="(" align="char" colspan="1" rowspan="1">14% (10)</td><td char="(" align="char" colspan="1" rowspan="1">21% (43)</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Mid-tier</td><td char="(" align="char" colspan="1" rowspan="1">24% (17)</td><td char="(" align="char" colspan="1" rowspan="1">22% (46)</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Comfortable</td><td char="(" align="char" colspan="1" rowspan="1">19% (14)</td><td char="(" align="char" colspan="1" rowspan="1">18% (38)</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Prosperous</td><td char="(" align="char" colspan="1" rowspan="1">14% (10)</td><td char="(" align="char" colspan="1" rowspan="1">21% (43)</td></tr><tr><td align="left" colspan="1" rowspan="1">Inflammatory bowel disease</td><td char="(" align="char" colspan="1" rowspan="1">12% (9)</td><td char="(" align="char" colspan="1" rowspan="1">13% (28)</td><td char="." align="char" colspan="1" rowspan="1">0.92</td></tr><tr><td align="left" colspan="1" rowspan="1">Hepatic insufficiency or liver failure</td><td char="(" align="char" colspan="1" rowspan="1">4.2% (3)</td><td char="(" align="char" colspan="1" rowspan="1">2.8% (6)</td><td char="." align="char" colspan="1" rowspan="1">0.56</td></tr><tr><td align="left" colspan="1" rowspan="1">Hypertension</td><td char="(" align="char" colspan="1" rowspan="1">57% (41)</td><td char="(" align="char" colspan="1" rowspan="1">60% (129)</td><td char="." align="char" colspan="1" rowspan="1">0.68</td></tr><tr><td align="left" colspan="1" rowspan="1">Diabetes</td><td char="(" align="char" colspan="1" rowspan="1">25% (18)</td><td char="(" align="char" colspan="1" rowspan="1">31% (66)</td><td char="." align="char" colspan="1" rowspan="1">0.37</td></tr><tr><td align="left" colspan="1" rowspan="1">COPD</td><td char="(" align="char" colspan="1" rowspan="1">17% (12)</td><td char="(" align="char" colspan="1" rowspan="1">16% (35)</td><td char="." align="char" colspan="1" rowspan="1">0.93</td></tr><tr><td align="left" colspan="1" rowspan="1">Anti-platelet medications</td><td char="(" align="char" colspan="1" rowspan="1">2.8% (2)</td><td char="(" align="char" colspan="1" rowspan="1">4.6% (10)</td><td char="." align="char" colspan="1" rowspan="1">0.5</td></tr><tr><td align="left" colspan="1" rowspan="1">Anti-coagulant medications</td><td char="(" align="char" colspan="1" rowspan="1">5.6% (4)</td><td char="(" align="char" colspan="1" rowspan="1">5.1% (11)</td><td char="." align="char" colspan="1" rowspan="1">0.88</td></tr><tr><td align="left" colspan="1" rowspan="1">Immunosuppressants</td><td char="(" align="char" colspan="1" rowspan="1">17% (12)</td><td char="(" align="char" colspan="1" rowspan="1">17% (36)</td><td char="." align="char" colspan="1" rowspan="1">1</td></tr><tr><td align="left" colspan="1" rowspan="1">Recurrent hernia</td><td char="(" align="char" colspan="1" rowspan="1">58% (42)</td><td char="(" align="char" colspan="1" rowspan="1">60% (129)</td><td char="." align="char" colspan="1" rowspan="1">0.83</td></tr></tbody></table></table-wrap><fig id="Fig1" position="float" orientation="portrait"><label>Fig.&#160;1</label><caption><p>Cohort similarities before and after matching</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="MO1" position="float" orientation="portrait" xlink:href="10029_2024_2976_Fig1_HTML.jpg"/></fig><table-wrap id="Tab2" position="float" orientation="portrait"><label>Table&#160;2</label><caption><p> Operative details</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="1" rowspan="1"/><th align="left" colspan="1" rowspan="1">Cannabis smoker <italic toggle="yes">n</italic>&#8201;=&#8201;72</th><th align="left" colspan="1" rowspan="1">Non-smoker <italic toggle="yes">n</italic>&#8201;=&#8201;216</th><th align="left" colspan="1" rowspan="1"><italic toggle="yes">p</italic> value</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">Elective case</td><td char="(" align="char" colspan="1" rowspan="1">100% (72)</td><td char="(" align="char" colspan="1" rowspan="1">99.7% (216)</td><td char="." align="char" colspan="1" rowspan="1">1</td></tr><tr><td align="left" colspan="1" rowspan="1">Intraoperative complication</td><td char="(" align="char" colspan="1" rowspan="1">6.9% (5)</td><td char="(" align="char" colspan="1" rowspan="1">2.8% (6)</td><td char="." align="char" colspan="1" rowspan="1">0.11</td></tr><tr><td align="left" colspan="1" rowspan="1">Concomitant procedure</td><td char="(" align="char" colspan="1" rowspan="1">11.1% (8)</td><td char="(" align="char" colspan="1" rowspan="1">9.7% (21)</td><td char="." align="char" colspan="1" rowspan="1">0.73</td></tr><tr><td align="left" colspan="1" rowspan="1">Hernia length, cm, median (IQR)</td><td char="(" align="char" colspan="1" rowspan="1">24 (20, 26)</td><td char="(" align="char" colspan="1" rowspan="1">23 (20, 26)</td><td char="." align="char" colspan="1" rowspan="1">0.93</td></tr><tr><td align="left" colspan="1" rowspan="1">Hernia width, cm, median (IQR)</td><td char="(" align="char" colspan="1" rowspan="1">15 (12, 18)</td><td char="(" align="char" colspan="1" rowspan="1">15 (12, 20)</td><td char="." align="char" colspan="1" rowspan="1">0.71</td></tr><tr><td align="left" colspan="1" rowspan="1">Mesh length, cm, median (IQR)</td><td char="(" align="char" colspan="1" rowspan="1">30 (30, 40)</td><td char="(" align="char" colspan="1" rowspan="1">30 (30, 46)</td><td char="." align="char" colspan="1" rowspan="1">0.34</td></tr><tr><td align="left" colspan="1" rowspan="1">Mesh width, cm, median (IQR)</td><td char="(" align="char" colspan="1" rowspan="1">30 (30, 46)</td><td char="(" align="char" colspan="1" rowspan="1">30 (30, 50)</td><td char="." align="char" colspan="1" rowspan="1">0.51</td></tr><tr><td align="left" colspan="1" rowspan="1">Fixation</td><td char="(" align="char" colspan="1" rowspan="1">57% (41)</td><td char="(" align="char" colspan="1" rowspan="1">70% (151)</td><td char="." align="char" colspan="1" rowspan="1">0.04</td></tr><tr><td align="left" colspan="1" rowspan="1">Fascial closure</td><td char="(" align="char" colspan="1" rowspan="1">91.7% (66)</td><td char="(" align="char" colspan="1" rowspan="1">94% (203)</td><td char="." align="char" colspan="1" rowspan="1">0.49</td></tr><tr><td align="left" colspan="1" rowspan="1">Subcutaneous drains used</td><td char="(" align="char" colspan="1" rowspan="1">27% (19)</td><td char="(" align="char" colspan="1" rowspan="1">21% (46)</td><td char="." align="char" colspan="1" rowspan="1">0.34</td></tr><tr><td align="left" colspan="1" rowspan="1">Subcutaneous flaps raised</td><td char="(" align="char" colspan="1" rowspan="1">4.2% (3)</td><td char="(" align="char" colspan="1" rowspan="1">8.3% (18)</td><td char="." align="char" colspan="1" rowspan="1">0.24</td></tr></tbody></table></table-wrap></p><p id="Par11">SSO rates for cannabis-smokers were 18% compared to 17% for non-smokers (<italic toggle="yes">p</italic>&#8201;=&#8201;0.86). SSI (11.1% vs 9.3%, <italic toggle="yes">p</italic>&#8201;=&#8201;0.65) and SSOPI (12% vs 12%, <italic toggle="yes">p</italic>&#8201;=&#8201;0.92) rates were also similar. There was no difference in readmission (12.5% vs 9.3%, <italic toggle="yes">p</italic>&#8201;=&#8201;0.43), or any postoperative complication (46% vs 43%, <italic toggle="yes">p</italic>&#8201;=&#8201;0.63). Reoperations were more common in the cannabis-smoker group (8.3% vs 2.8%, <italic toggle="yes">p</italic>&#8201;=&#8201;0.041), and were mostly related to major wound complications in the cannabis-smoker group (5/72 vs 2/216, <italic toggle="yes">p</italic>&#8201;=&#8201;0.004) and postoperative bleeding in the non-smoker group (0/72 vs 3/216, <italic toggle="yes">p</italic>&#8201;=&#8201;0.046). No mesh excisions occurred in this cohort (Table&#160;<xref rid="Tab3" ref-type="table">3</xref>).<table-wrap id="Tab3" position="float" orientation="portrait"><label>Table&#160;3</label><caption><p> 30&#160;day outcomes</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="1" rowspan="1"/><th align="left" colspan="1" rowspan="1">Cannabis smoker <italic toggle="yes">n</italic>&#8201;=&#8201;72</th><th align="left" colspan="1" rowspan="1">Non-smoker <italic toggle="yes">n</italic>&#8201;=&#8201;216</th><th align="left" colspan="1" rowspan="1"><italic toggle="yes">p</italic> value</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">Length of stay, days, median (IQR)</td><td align="left" colspan="1" rowspan="1">5 (4, 6)</td><td align="left" colspan="1" rowspan="1">6 (4, 7)</td><td char="." align="char" colspan="1" rowspan="1">0.21</td></tr><tr><td align="left" colspan="1" rowspan="1">Readmission</td><td align="left" colspan="1" rowspan="1">12.5% (9)</td><td align="left" colspan="1" rowspan="1">9.3% (20)</td><td char="." align="char" colspan="1" rowspan="1">0.43</td></tr><tr><td align="left" colspan="1" rowspan="1">Reoperation</td><td align="left" colspan="1" rowspan="1">8.3% (6)</td><td align="left" colspan="1" rowspan="1">2.8% (6)</td><td char="." align="char" rowspan="6" colspan="1">0.04</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Bowel obstruction</td><td align="left" colspan="1" rowspan="1">0</td><td align="left" colspan="1" rowspan="1">1</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Major wound complication</td><td align="left" colspan="1" rowspan="1">5</td><td align="left" colspan="1" rowspan="1">2</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Postoperative bleeding</td><td align="left" colspan="1" rowspan="1">0</td><td align="left" colspan="1" rowspan="1">3</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Unrelated intra-abdominal pathology</td><td align="left" colspan="1" rowspan="1">1</td><td align="left" colspan="1" rowspan="1">0</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Mesh excision</td><td align="left" colspan="1" rowspan="1">0</td><td align="left" colspan="1" rowspan="1">0</td></tr><tr><td align="left" colspan="1" rowspan="1">Any postoperative complications</td><td align="left" colspan="1" rowspan="1">46% (33)</td><td align="left" colspan="1" rowspan="1">43% (92)</td><td char="." align="char" colspan="1" rowspan="1">0.63</td></tr><tr><td align="left" colspan="1" rowspan="1">SSI</td><td align="left" colspan="1" rowspan="1">11.1% (8)</td><td align="left" colspan="1" rowspan="1">9.3% (20)</td><td char="." align="char" colspan="1" rowspan="1">0.65</td></tr><tr><td align="left" colspan="1" rowspan="1">SSO</td><td align="left" colspan="1" rowspan="1">18% (13)</td><td align="left" colspan="1" rowspan="1">17% (37)</td><td char="." align="char" colspan="1" rowspan="1">0.73</td></tr><tr><td align="left" colspan="1" rowspan="1">SSOPI</td><td align="left" colspan="1" rowspan="1">12% (9)</td><td align="left" colspan="1" rowspan="1">12% (26)</td><td char="." align="char" colspan="1" rowspan="1">0.92</td></tr><tr><td align="left" colspan="1" rowspan="1">Pulmonary embolism</td><td align="left" colspan="1" rowspan="1">1.4% (1)</td><td align="left" colspan="1" rowspan="1">1.9% (4)</td><td char="." align="char" colspan="1" rowspan="1">0.8</td></tr><tr><td align="left" colspan="1" rowspan="1">Deep vein thrombosis</td><td align="left" colspan="1" rowspan="1">2.8% (2)</td><td align="left" colspan="1" rowspan="1">0.46% (1)</td><td char="." align="char" colspan="1" rowspan="1">0.094</td></tr><tr><td align="left" colspan="1" rowspan="1">Myocardial infarction</td><td align="left" colspan="1" rowspan="1">0</td><td align="left" colspan="1" rowspan="1">0.93% (2)</td><td char="." align="char" colspan="1" rowspan="1">0.41</td></tr><tr><td align="left" colspan="1" rowspan="1">Pneumonia</td><td align="left" colspan="1" rowspan="1">1.4% (1)</td><td align="left" colspan="1" rowspan="1">2.3% (5)</td><td char="." align="char" colspan="1" rowspan="1">0.63</td></tr><tr><td align="left" colspan="1" rowspan="1">Respiratory failure</td><td align="left" colspan="1" rowspan="1">1.4% (1)</td><td align="left" colspan="1" rowspan="1">2.8% (6)</td><td char="." align="char" colspan="1" rowspan="1">0.51</td></tr></tbody></table></table-wrap></p><p id="Par12">Abdominal wall-specific quality-of-life (HerQLes) scores were not significantly different at baseline for both groups (22 [11, 41] vs. 35 [14, 55], <italic toggle="yes">p</italic>&#8201;=&#8201;0.06), and were worse for cannabis-smokers compared to non-smokers at 30&#160;days (30 [12, 50] vs 38 [20, 67], <italic toggle="yes">p</italic>&#8201;=&#8201;0.032), but not significantly different at 1&#160;year postoperatively (72 [53, 90] vs 78 [57, 92], <italic toggle="yes">p</italic>&#8201;=&#8201;0.39). Pain scores (PROMIS 3a-Pain Intensity) were worse for cannabis-smokers compared to non-smokers at 30&#160;days postoperatively (52 [46, 58] vs 49 [44, 54], <italic toggle="yes">p</italic>&#8201;=&#8201;0.01), but there were no differences at 6&#160;months or 1&#160;year postoperatively (<italic toggle="yes">p</italic>&#8201;&gt;&#8201;0.05 for all) (Table&#160;<xref rid="Tab4" ref-type="table">4</xref>; Fig.&#160;<xref rid="Fig2" ref-type="fig">2</xref>). There were no differences in demographics for patients with any patient-reported outcomes available compared to patients with no patient-reported outcomes available (Table&#160;<xref rid="Tab5" ref-type="table">5</xref>).<table-wrap id="Tab4" position="float" orientation="portrait"><label>Table&#160;4</label><caption><p> Patient-reported outcomes</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="1" rowspan="1"/><th align="left" colspan="1" rowspan="1"><italic toggle="yes">N</italic></th><th align="left" colspan="1" rowspan="1">Cannabis smoker <italic toggle="yes">n</italic>&#8201;=&#8201;72</th><th align="left" colspan="1" rowspan="1">Non-smoker <italic toggle="yes">n</italic>&#8201;=&#8201;216</th><th align="left" colspan="1" rowspan="1"><italic toggle="yes">p</italic> value</th></tr></thead><tbody><tr><td align="left" colspan="5" rowspan="1">HerQLes score, median (IQR)</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Summary score at baseline</td><td char="." align="char" colspan="1" rowspan="1">194</td><td char="(" align="char" colspan="1" rowspan="1">22 (11, 41)</td><td char="(" align="char" colspan="1" rowspan="1">35 (14, 55)</td><td char="." align="char" colspan="1" rowspan="1">0.06</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Summary score at 30&#160;days</td><td char="." align="char" colspan="1" rowspan="1">205</td><td char="(" align="char" colspan="1" rowspan="1">30 (12, 50)</td><td char="(" align="char" colspan="1" rowspan="1">38 (20, 67)</td><td char="." align="char" colspan="1" rowspan="1">0.032</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Change from baseline to 30&#160;days</td><td char="." align="char" colspan="1" rowspan="1">161</td><td char="(" align="char" colspan="1" rowspan="1">3.3 (&#8722;&#160;10, 20)</td><td char="(" align="char" colspan="1" rowspan="1">6.7 (&#8722;&#160;10, 25)</td><td char="." align="char" colspan="1" rowspan="1">0.59</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Summary score at 6&#160;months</td><td char="." align="char" colspan="1" rowspan="1">80</td><td char="(" align="char" colspan="1" rowspan="1">51 (19, 86)</td><td char="(" align="char" colspan="1" rowspan="1">81 (49, 92)</td><td char="." align="char" colspan="1" rowspan="1">0.077</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Change from baseline to 6&#160;months</td><td char="." align="char" colspan="1" rowspan="1">58</td><td char="(" align="char" colspan="1" rowspan="1">14.2 (2.5, 17.9)</td><td char="(" align="char" colspan="1" rowspan="1">40 (7.5, 55.8)</td><td char="." align="char" colspan="1" rowspan="1">0.037</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Summary score at 1&#160;year</td><td char="." align="char" colspan="1" rowspan="1">120</td><td char="(" align="char" colspan="1" rowspan="1">72 (53, 90)</td><td char="(" align="char" colspan="1" rowspan="1">78 (57, 92)</td><td char="." align="char" colspan="1" rowspan="1">0.39</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Change from baseline to 1&#160;year</td><td char="." align="char" colspan="1" rowspan="1">102</td><td char="(" align="char" colspan="1" rowspan="1">32 (11, 58)</td><td char="(" align="char" colspan="1" rowspan="1">33 (18, 58)</td><td char="." align="char" colspan="1" rowspan="1">0.72</td></tr><tr><td align="left" colspan="5" rowspan="1">PROMIS score, median (IQR)</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Summary score at baseline</td><td char="." align="char" colspan="1" rowspan="1">194</td><td char="(" align="char" colspan="1" rowspan="1">51 (44, 54)</td><td char="(" align="char" colspan="1" rowspan="1">46 (40, 54)</td><td char="." align="char" colspan="1" rowspan="1">0.33</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Summary score at 30&#160;days</td><td char="." align="char" colspan="1" rowspan="1">206</td><td char="(" align="char" colspan="1" rowspan="1">52 (46, 58)</td><td char="(" align="char" colspan="1" rowspan="1">49 (44, 54)</td><td char="." align="char" colspan="1" rowspan="1">0.01</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Change from baseline to 30&#160;days</td><td char="." align="char" colspan="1" rowspan="1">161</td><td char="(" align="char" colspan="1" rowspan="1">2.7 (&#8722;&#160;3.1, 8.6)</td><td char="(" align="char" colspan="1" rowspan="1">0 (&#8722;&#160;6.2, 8.6)</td><td char="." align="char" colspan="1" rowspan="1">0.46</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Summary score at 6&#160;months</td><td char="." align="char" colspan="1" rowspan="1">78</td><td char="(" align="char" colspan="1" rowspan="1">52 (46, 58)</td><td char="(" align="char" colspan="1" rowspan="1">40 (31, 48)</td><td char="." align="char" colspan="1" rowspan="1">0.77</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Change from baseline to 6&#160;months</td><td char="." align="char" colspan="1" rowspan="1">57</td><td char="(" align="char" colspan="1" rowspan="1">&#8722;&#160;7.9 (&#8722;&#160;9.5, &#8722;&#160;5.6)</td><td char="(" align="char" colspan="1" rowspan="1">&#8722;&#160;8.6 (&#8722;&#160;13.5, 0)</td><td char="." align="char" colspan="1" rowspan="1">0.87</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Summary score at 1&#160;year</td><td char="." align="char" colspan="1" rowspan="1">120</td><td char="(" align="char" colspan="1" rowspan="1">38 (31, 46)</td><td char="(" align="char" colspan="1" rowspan="1">31 (31, 46)</td><td char="." align="char" colspan="1" rowspan="1">0.65</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Change from baseline to 1&#160;year</td><td char="." align="char" colspan="1" rowspan="1">102</td><td char="(" align="char" colspan="1" rowspan="1">&#8722;&#160;8.2 (&#8722;&#160;17.1, 0)</td><td char="(" align="char" colspan="1" rowspan="1">&#8722;&#160;9.5 (&#8722;&#160;14.5, 0)</td><td char="." align="char" colspan="1" rowspan="1">0.96</td></tr></tbody></table></table-wrap><fig id="Fig2" position="float" orientation="portrait"><label>Fig.&#160;2</label><caption><p>Histogram of HerQLes and PROMIS scores at baseline (<bold>A</bold>, <bold>D</bold>), 30&#160;day follow-up (<bold>B</bold>, <bold>E</bold>), and 1&#160;year postoperatively (<bold>C</bold>, <bold>F</bold>)</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="MO2" position="float" orientation="portrait" xlink:href="10029_2024_2976_Fig2_HTML.jpg"/></fig><table-wrap id="Tab5" position="float" orientation="portrait"><label>Table&#160;5</label><caption><p> Comparison of patients with and without patient-reported outcomes</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="1" rowspan="1"/><th align="left" colspan="1" rowspan="1">Patient-reported outcomes available <italic toggle="yes">n</italic>&#8201;=&#8201;247</th><th align="left" colspan="1" rowspan="1">Patient-reported outcomes unavailable <italic toggle="yes">n</italic>&#8201;=&#8201;41</th><th align="left" colspan="1" rowspan="1"><italic toggle="yes">p</italic> value</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">Cannabis smoker</td><td char="(" align="char" colspan="1" rowspan="1">25% (61)</td><td char="(" align="char" colspan="1" rowspan="1">27% (11)</td><td char="." align="char" colspan="1" rowspan="1">0.77</td></tr><tr><td align="left" colspan="1" rowspan="1">Male</td><td char="(" align="char" colspan="1" rowspan="1">53% (131)</td><td char="(" align="char" colspan="1" rowspan="1">54% (22)</td><td char="." align="char" colspan="1" rowspan="1">0.94</td></tr><tr><td align="left" colspan="1" rowspan="1">White race</td><td char="(" align="char" colspan="1" rowspan="1">84% (207)</td><td char="(" align="char" colspan="1" rowspan="1">76% (31)</td><td char="." align="char" colspan="1" rowspan="1">0.41</td></tr><tr><td align="left" colspan="1" rowspan="1">Age, years, median (IQR)</td><td char="(" align="char" colspan="1" rowspan="1">54 (45,62)</td><td char="(" align="char" colspan="1" rowspan="1">53 (44, 60)</td><td char="." align="char" colspan="1" rowspan="1">0.54</td></tr><tr><td align="left" colspan="1" rowspan="1">BMI, kg/m<sup>2</sup>, median (IQR)</td><td char="(" align="char" colspan="1" rowspan="1">32 (29, 36)</td><td char="(" align="char" colspan="1" rowspan="1">32 (28,35)</td><td char="." align="char" colspan="1" rowspan="1">0.36</td></tr><tr><td align="left" colspan="1" rowspan="1">Current tobacco use</td><td char="(" align="char" colspan="1" rowspan="1">12% (30)</td><td char="(" align="char" colspan="1" rowspan="1">5% (2)</td><td char="." align="char" colspan="1" rowspan="1">0.17</td></tr><tr><td align="left" colspan="4" rowspan="1">Distressed community index</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Distressed</td><td char="(" align="char" colspan="1" rowspan="1">22% (53)</td><td char="(" align="char" colspan="1" rowspan="1">17% (7)</td><td char="." align="char" rowspan="5" colspan="1">0.76</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;At risk</td><td char="(" align="char" colspan="1" rowspan="1">19% (45)</td><td char="(" align="char" colspan="1" rowspan="1">20% (8)</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Mid-tier</td><td char="(" align="char" colspan="1" rowspan="1">22% (53)</td><td char="(" align="char" colspan="1" rowspan="1">24% (10)</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Comfortable</td><td char="(" align="char" colspan="1" rowspan="1">19% (45)</td><td char="(" align="char" colspan="1" rowspan="1">20% (8)</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Prosperous</td><td char="(" align="char" colspan="1" rowspan="1">20% (47)</td><td char="(" align="char" colspan="1" rowspan="1">15% (6)</td></tr><tr><td align="left" colspan="1" rowspan="1">Inflammatory bowel disease</td><td char="(" align="char" colspan="1" rowspan="1">15% (6)</td><td char="(" align="char" colspan="1" rowspan="1">7% (3)</td><td char="." align="char" colspan="1" rowspan="1">0.25</td></tr><tr><td align="left" colspan="1" rowspan="1">Hepatic insufficiency or liver failure</td><td char="(" align="char" colspan="1" rowspan="1">3% (8)</td><td char="(" align="char" colspan="1" rowspan="1">2% (1)</td><td char="." align="char" colspan="1" rowspan="1">0.79</td></tr><tr><td align="left" colspan="1" rowspan="1">Hypertension</td><td char="(" align="char" colspan="1" rowspan="1">60% (148)</td><td char="(" align="char" colspan="1" rowspan="1">54% (22)</td><td char="." align="char" colspan="1" rowspan="1">0.45</td></tr><tr><td align="left" colspan="1" rowspan="1">Diabetes</td><td char="(" align="char" colspan="1" rowspan="1">29% (72)</td><td char="(" align="char" colspan="1" rowspan="1">29% (12)</td><td char="." align="char" colspan="1" rowspan="1">0.99</td></tr><tr><td align="left" colspan="1" rowspan="1">COPD</td><td char="(" align="char" colspan="1" rowspan="1">17% (41)</td><td char="(" align="char" colspan="1" rowspan="1">15% (6)</td><td char="." align="char" colspan="1" rowspan="1">0.75</td></tr><tr><td align="left" colspan="1" rowspan="1">Anti-platelet medications</td><td char="(" align="char" colspan="1" rowspan="1">3% (8)</td><td char="(" align="char" colspan="1" rowspan="1">10% (4)</td><td char="." align="char" colspan="1" rowspan="1">0.053</td></tr><tr><td align="left" colspan="1" rowspan="1">Anti-coagulant medications</td><td char="(" align="char" colspan="1" rowspan="1">5% (12)</td><td char="(" align="char" colspan="1" rowspan="1">7% (3)</td><td char="." align="char" colspan="1" rowspan="1">0.51</td></tr><tr><td align="left" colspan="1" rowspan="1">Immunosuppressants</td><td char="(" align="char" colspan="1" rowspan="1">17% (41)</td><td char="(" align="char" colspan="1" rowspan="1">17% (7)</td><td char="." align="char" colspan="1" rowspan="1">0.94</td></tr><tr><td align="left" colspan="1" rowspan="1">Recurrent hernia</td><td char="(" align="char" colspan="1" rowspan="1">59% (145)</td><td char="(" align="char" colspan="1" rowspan="1">63% (26)</td><td char="." align="char" colspan="1" rowspan="1">0.57</td></tr></tbody></table></table-wrap></p></sec><sec id="Sec4"><title>Discussion</title><p id="Par13">In this propensity score-matched study, we sought to determine if cannabis use has an association with postoperative wound morbidity or reoperations in patients undergoing clean open abdominal wall reconstruction with retromuscular placement of synthetic mesh. Although there were no major differences in overall wound complication rates, cannabis users appeared to have more severe wound complications requiring reoperation. There was a difference in patient-reported quality of life, with cannabis-smokers having worse early postoperative quality of life and pain scores which eventually normalized with longer term follow-up.</p><p id="Par14">There is a gap in knowledge regarding the implications of cannabis and wound healing. In vitro models have shown that cannabidiol inhibits pro-inflammatory pathways and cannabinoid receptors have been shown to augment multiple cellular mechanism of wound healing [<xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR15">15</xref>]. There is growing interest in the effect of cannabis on wound health with data in orthopedic literature with conflicting findings regarding outcomes following orthopedic and plastic surgeries [<xref ref-type="bibr" rid="CR16">16</xref>&#8211;<xref ref-type="bibr" rid="CR19">19</xref>]. Our data found similar rates of wound complications between cannabis-smokers and non-smokers, but severity of complications was worse for patients with cannabis use. More cannabis-smokers required reoperation for wound complications, though notably there were no mesh excisions in either patient group. Wound complications for patients with regular cannabis use will be important to follow to understand the clinical impact on wound healing.</p><p id="Par15">Pain control following hernia repair is an important consideration for all patients but may be specifically affected by cannabis use, given known analgesic effects of cannabis and pharmacologic interactions with opioids [<xref ref-type="bibr" rid="CR20">20</xref>&#8211;<xref ref-type="bibr" rid="CR22">22</xref>]. Retrospective cohorts have also shown significantly higher opioid consumption and pain scores in cannabis-smokers following motor vehicle accidents, major orthopedic surgeries, IBD-related surgery, and gynecologic oncology surgery [<xref ref-type="bibr" rid="CR23">23</xref>&#8211;<xref ref-type="bibr" rid="CR28">28</xref>]. In chronic smokers, abstinence may also produce withdrawal which is associated with anxiety, behavioral changes, and abdominal pain, which may present diagnostic confusion postoperatively [<xref ref-type="bibr" rid="CR29">29</xref>]. Clinical trials in surgical patients have explored cannabis as an adjunctive analgesic, without clear benefit [<xref ref-type="bibr" rid="CR30">30</xref>&#8211;<xref ref-type="bibr" rid="CR33">33</xref>]. Our data show a higher perception of pain in cannabis-smokers at 30&#160;day follow-up postoperatively, which may be a reflection of a lower pain threshold or increased requirement for analgesia postoperatively. Given this observation of increased pain perception postoperatively, surgeons should counsel patients with active cannabis use regarding postoperative expectation setting for pain and analgesia management. In a similar vein, the baseline quality-of-life scores for the cannabis-smokers were surprisingly low, though not statistically significant at baseline, in this cohort and showed less improvement at 30&#160;days and 6&#160;months after surgery compared to non-smokers. While we are not positioned to explain causation, it is possible that the lower patient-reported quality of life is associated with increased pain perception or the higher reoperation rate. A previous prospective cohort study of elective surgical patients similarly demonstrated worse patient-reported pain and quality of life in cannabis-smokers compared to non-smokers despite similar surgical outcomes [<xref ref-type="bibr" rid="CR34">34</xref>]. Albelo et al. similarly demonstrated worse patient-reported outcomes in multiple domains for cannabis-smokers 2&#160;years after orthopedic surgery [<xref ref-type="bibr" rid="CR35">35</xref>]. Supporting the idea that there is a correlation between cannabis use and quality of life prior to propensity score matching, cannabis-smokers represented significantly more distressed communities and more non-white racial groups, so it is important to acknowledge that there are likely external factors confounding quality of life for the patients with active cannabis use. Healthcare professionals have traditionally espoused negative attitudes towards patients with substance use disorders, so surgeons should be cognizant of their biases in this area and how they affect patient interactions and possibly worsen existing disparities [<xref ref-type="bibr" rid="CR36">36</xref>].</p><p id="Par16">The medical community has become increasingly aware of cannabis use in surgical patients as evidenced by a growing body of literature on the topic, and it is important for hernia surgeons to understand the implications on perioperative care and outcomes. The American Society for Regional Anesthesia (ASRA) released guidelines in 2023 on perioperative considerations for patients with cannabis use [<xref ref-type="bibr" rid="CR20">20</xref>, <xref ref-type="bibr" rid="CR23">23</xref>, <xref ref-type="bibr" rid="CR37">37</xref>]. In addition to known pharmacologic interactions, cannabis has been shown to predispose chronic smokers to a 20% increased risk of postoperative nausea and vomiting and preoperative cannabinoid use is also associated with higher levels of postoperative pain. Cannabinoids also have significant cardiovascular effects with activating sympathetic effects in acute usage as well as increased parasympathetic tone with chronic usage that can contribute to bradycardia and hypotension and may be associated with an increased risk of postoperative myocardial infarction [<xref ref-type="bibr" rid="CR38">38</xref>, <xref ref-type="bibr" rid="CR39">39</xref>]. Additionally, there may be some benefit to cannabis cessation prior to surgery, although the duration of this requires further inquiry [<xref ref-type="bibr" rid="CR20">20</xref>, <xref ref-type="bibr" rid="CR40">40</xref>]. A recent cohort study of 12,422 hospitalizations after major, non-cardiac surgery found a higher incidence of composite complications and mortality in patients with cannabis use disorder (7.73% vs 6.57%) [<xref ref-type="bibr" rid="CR41">41</xref>]. Similar large cohort NIS studies in elective spine surgery, vascular surgery, and orthopedic and bariatric surgery have also reported increased odds ratios of postoperative complications in cannabis use disorder including thromboembolic events, respiratory complications, neurologic complications, sepsis, myocardial infarction, stroke, and increased length of stay [<xref ref-type="bibr" rid="CR42">42</xref>&#8211;<xref ref-type="bibr" rid="CR45">45</xref>]. Our data revealed no significant differences in cardiovascular or respiratory complications in patients with known cannabis use, though our patient population was significantly different. The underlying cardiovascular and neurologic risk factors for patients undergoing vascular surgery for example are significantly different from the average profile of a patient undergoing hernia repair. Additionally, the patients included in our study did not require a diagnosis of cannabis use disorder for inclusion, which likely skews NIS data towards patients with heavy cannabis consumption. More in line with our findings, similar postoperative outcomes for cannabis-smokers and non-smokers have been demonstrated in smaller cohorts of bariatric and non-cardiac surgical patients [<xref ref-type="bibr" rid="CR46">46</xref>&#8211;<xref ref-type="bibr" rid="CR50">50</xref>]. The overall incidence of major medical complications in previous large database reviews was low overall, but it is important to consider the clinical significance of statistically significant p values. While a difference in composite outcomes may have led to detection of relatively rare events, the clinical significance of this finding in our patient population is unclear [<xref ref-type="bibr" rid="CR41">41</xref>].</p><p id="Par17">One of the main limitations of studying cannabis use is the risk of underreporting of substance use, which may bias the results towards the null hypothesis. At the time of this data capture, only medical cannabis use is legal in Ohio, and regardless of legal status, there is cultural stigma associated with cannabis use, both of which could disincentivize forthcoming patient-reported use. The reason for cannabis use was not captured in this study; for example the number of patients smoking for chronic pain may have influenced the rates of chronic pain and hernia-specific quality of life. Our definition of cannabis use did not distinguish frequency of use, so it is unclear from these data if outcomes might differ for routine chronic smokers versus more episodic smokers. Smoking was the only qualifying route of administration included, which restricts us from commenting on other means of ingestion, which may carry unique physiologic effects. The retrospective nature of this work presents an opportunity for selection bias and limits the follow-up; however, these data can be used for hypothesis generation and power calculation for future prospective studies. Propensity score matching adjusted for baseline differences in the cohorts but presents a risk for introducing unanticipated biases.</p></sec><sec id="Sec5"><title>Conclusion</title><p id="Par18">While cannabis is a controversial issue, its accessibility and use are increasing with changes in legislation, compelling surgeons to better understand how cannabis use may affect postoperative outcomes. Active cannabis use is not prohibitive for elective open, clean ventral hernia repairs, with retromuscular synthetic mesh placement, but surgeons should take a full history of cannabis use and counsel patients about potentially higher risk for more severe wound complications. Additionally, hernia surgeons should be aware of the differences in pain perception after complex abdominal wall reconstruction in cannabis-smokers and potentially adjust expectations and perioperative management.</p></sec></body><back><fn-group><fn><p><bold>Publisher's Note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><notes notes-type="funding-information"><title>Funding</title><p>The authors accepted no funding or financial support related to this work.</p></notes><notes><title>Declarations</title><notes id="FPar1" notes-type="COI-statement"><title>Conflict of interest</title><p id="Par19">Clayton Petro has research grants from Central Surgical Association, American Hernia Society and SAGES and acts as a consultant for BD and Surgimatix. Michael Rosen is the medical director of Abdominal Core Health Quality Collaborative and has stock options with Ariste. Ajita Prabhu accepts speaking fees and research support paid to institution from Intuitive Surgical, consulting fees and is on the Advisory Board for CMR Surgical and is on the Advisory Board for Surgimatix. Lucas Beffa accepts honoraria from Intuitive Surgical. Sara Maskal accepted a resident research grant from ACHQC. Megan Melland-Smith, Nir Messer, Benjamin Miller, Ryan Ellis, Sharon Phillips, and Justin Foreman have no financial disclosures.</p></notes><notes id="FPar2"><title>Ethical approval, Human and animal rights and Informed consent</title><p>This project was conducted under approval by our Institutional Review Board.</p></notes></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><mixed-citation publication-type="other">Substance Abuse and Mental Health Services Administration (2021) Key substance use and mental health indicators in the United States: results from the 2020 national survey on drug use and health. substance abuse and mental health services administration. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.samhsa.gov/data/">https://www.samhsa.gov/data/</ext-link> Accessed 4 July 2023</mixed-citation></ref><ref id="CR2"><label>2.</label><mixed-citation publication-type="other">National Conference of State Legislatures (2023) State medical cannabis laws. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.ncsl.org/health/state-medical-cannabis-laws">https://www.ncsl.org/health/state-medical-cannabis-laws</ext-link>. Accessed 4 July 2023</mixed-citation></ref><ref id="CR3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Izzo</surname><given-names>AA</given-names></name><name name-style="western"><surname>Fezza</surname><given-names>F</given-names></name><name name-style="western"><surname>Capasso</surname><given-names>R</given-names></name><etal/></person-group><article-title>Cannabinoid CB<sub>1</sub>-receptor mediated regulation of gastrointestinal motility in mice in a model of intestinal inflammation: cannabinoids, intestinal motility and inflammation</article-title><source>Br J Pharmacol</source><year>2001</year><volume>134</volume><issue>3</issue><fpage>563</fpage><lpage>570</lpage><pub-id pub-id-type="doi">10.1038/sj.bjp.0704293</pub-id><pub-id pub-id-type="pmid">11588110</pub-id><pub-id pub-id-type="pmcid">PMC1572987</pub-id></element-citation></ref><ref id="CR4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Izzo</surname><given-names>AA</given-names></name><name name-style="western"><surname>Mascolo</surname><given-names>N</given-names></name><name name-style="western"><surname>Pinto</surname><given-names>L</given-names></name><name name-style="western"><surname>Capasso</surname><given-names>R</given-names></name><name name-style="western"><surname>Capasso</surname><given-names>F</given-names></name></person-group><article-title>The role of cannabinoid receptors in intestinal motility, defaecation and diarrhoea in rats</article-title><source>Eur J Pharmacol</source><year>1999</year><volume>384</volume><issue>1</issue><fpage>37</fpage><lpage>42</lpage><pub-id pub-id-type="doi">10.1016/S0014-2999(99)00673-1</pub-id><pub-id pub-id-type="pmid">10611417</pub-id></element-citation></ref><ref id="CR5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Abdel-Salam</surname><given-names>O</given-names></name></person-group><article-title>Gastric acid inhibitory and gastric protective effects of cannabis and cannabinoids</article-title><source>Asian Pac J Trop Med</source><year>2016</year><volume>9</volume><issue>5</issue><fpage>413</fpage><lpage>419</lpage><pub-id pub-id-type="doi">10.1016/j.apjtm.2016.04.021</pub-id><pub-id pub-id-type="pmid">27261847</pub-id></element-citation></ref><ref id="CR6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bakshi</surname><given-names>C</given-names></name><name name-style="western"><surname>Barrett</surname><given-names>AM</given-names></name></person-group><article-title>Impact of recreational and medicinal marijuana on surgical patients: a review</article-title><source>Am J Surg</source><year>2019</year><volume>217</volume><issue>4</issue><fpage>783</fpage><lpage>786</lpage><pub-id pub-id-type="doi">10.1016/j.amjsurg.2018.10.053</pub-id><pub-id pub-id-type="pmid">30471810</pub-id></element-citation></ref><ref id="CR7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Poulose</surname><given-names>BK</given-names></name><name name-style="western"><surname>Roll</surname><given-names>S</given-names></name><name name-style="western"><surname>Murphy</surname><given-names>JW</given-names></name><etal/></person-group><article-title>Design and implementation of the americas hernia society quality collaborative (AHSQC): improving value in hernia care</article-title><source>Hernia</source><year>2016</year><volume>20</volume><issue>2</issue><fpage>177</fpage><lpage>189</lpage><pub-id pub-id-type="doi">10.1007/s10029-016-1477-7</pub-id><pub-id pub-id-type="pmid">26936373</pub-id></element-citation></ref><ref id="CR8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kanters</surname><given-names>AE</given-names></name><name name-style="western"><surname>Krpata</surname><given-names>DM</given-names></name><name name-style="western"><surname>Blatnik</surname><given-names>JA</given-names></name><name name-style="western"><surname>Novitsky</surname><given-names>YM</given-names></name><name name-style="western"><surname>Rosen</surname><given-names>MJ</given-names></name></person-group><article-title>Modified hernia grading scale to stratify surgical site occurrence after open ventral hernia repairs</article-title><source>J Am Coll Surg</source><year>2012</year><volume>215</volume><issue>6</issue><fpage>787</fpage><lpage>793</lpage><pub-id pub-id-type="doi">10.1016/j.jamcollsurg.2012.08.012</pub-id><pub-id pub-id-type="pmid">22999328</pub-id></element-citation></ref><ref id="CR9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Krpata</surname><given-names>DM</given-names></name><name name-style="western"><surname>Schmotzer</surname><given-names>BJ</given-names></name><name name-style="western"><surname>Flocke</surname><given-names>S</given-names></name><etal/></person-group><article-title>Design and initial implementation of HerQLes: a hernia-related quality-of-life survey to assess abdominal wall function</article-title><source>J Am Coll Surg</source><year>2012</year><volume>215</volume><issue>5</issue><fpage>635</fpage><lpage>642</lpage><pub-id pub-id-type="doi">10.1016/j.jamcollsurg.2012.06.412</pub-id><pub-id pub-id-type="pmid">22867715</pub-id></element-citation></ref><ref id="CR10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Renshaw</surname><given-names>SM</given-names></name><name name-style="western"><surname>Gupta</surname><given-names>A</given-names></name><name name-style="western"><surname>Poulose</surname><given-names>BK</given-names></name></person-group><article-title>Establishing the minimal clinically important difference for the hernia-related quality of life survey (HerQLes)</article-title><source>Am J Surg</source><year>2022</year><volume>223</volume><issue>2</issue><fpage>245</fpage><lpage>249</lpage><pub-id pub-id-type="doi">10.1016/j.amjsurg.2021.06.018</pub-id><pub-id pub-id-type="pmid">34256930</pub-id></element-citation></ref><ref id="CR11"><label>11.</label><mixed-citation publication-type="other">PROMIS Health Organization and PROMIS Cooperative Group (2008&#8211;2012) Instrument: PROMIS pain intensity&#8212;Short Form 3a v1.0 | NIDA CTN common data elements. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://cde.nida.nih.gov/instrument/0a481bfb-a5e6-3c84-e050-bb89ad43314d">https://cde.nida.nih.gov/instrument/0a481bfb-a5e6-3c84-e050-bb89ad43314d</ext-link>. Accessed 20 December 2022</mixed-citation></ref><ref id="CR12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Revicki</surname><given-names>DA</given-names></name><name name-style="western"><surname>Chen</surname><given-names>WH</given-names></name><name name-style="western"><surname>Harnam</surname><given-names>N</given-names></name><etal/></person-group><article-title>Development and psychometric analysis of the PROMIS pain behavior item bank</article-title><source>Pain</source><year>2009</year><volume>146</volume><issue>1</issue><fpage>158</fpage><lpage>169</lpage><pub-id pub-id-type="doi">10.1016/j.pain.2009.07.029</pub-id><pub-id pub-id-type="pmid">19683873</pub-id><pub-id pub-id-type="pmcid">PMC2775487</pub-id></element-citation></ref><ref id="CR13"><label>13.</label><mixed-citation publication-type="other">Economic Innovation Group (2022) 2022 DCI interactive map. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://eig.org/distressed-communities/2022-dci-interactive-map/">https://eig.org/distressed-communities/2022-dci-interactive-map/</ext-link>. Accessed 21 May 2023.</mixed-citation></ref><ref id="CR14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sangiovanni</surname><given-names>E</given-names></name><name name-style="western"><surname>Fumagalli</surname><given-names>M</given-names></name><name name-style="western"><surname>Pacchetti</surname><given-names>B</given-names></name><etal/></person-group><article-title>Cannabis sativa L. extract and cannabidiol inhibit in vitro mediators of skin inflammation and wound injury</article-title><source>Phytother Res</source><year>2019</year><volume>33</volume><issue>8</issue><fpage>2083</fpage><lpage>2093</lpage><pub-id pub-id-type="doi">10.1002/ptr.6400</pub-id><pub-id pub-id-type="pmid">31250491</pub-id></element-citation></ref><ref id="CR15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shao</surname><given-names>K</given-names></name><name name-style="western"><surname>Stewart</surname><given-names>C</given-names></name><name name-style="western"><surname>Grant-Kels</surname><given-names>JM</given-names></name></person-group><article-title>Cannabis and the skin</article-title><source>Clin Dermatol</source><year>2021</year><volume>39</volume><issue>5</issue><fpage>784</fpage><lpage>795</lpage><pub-id pub-id-type="doi">10.1016/j.clindermatol.2021.05.006</pub-id><pub-id pub-id-type="pmid">34785006</pub-id></element-citation></ref><ref id="CR16"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Weisberg</surname><given-names>MD</given-names></name><name name-style="western"><surname>Ng</surname><given-names>MK</given-names></name><name name-style="western"><surname>Magruder</surname><given-names>ML</given-names></name><name name-style="western"><surname>Vakharia</surname><given-names>RM</given-names></name><name name-style="western"><surname>Roche</surname><given-names>MW</given-names></name><name name-style="western"><surname>Erez</surname><given-names>O</given-names></name></person-group><article-title>The association of cannabis use disorder and perioperative complications after primary total knee arthroplasty</article-title><source>J Am Acad Orthop Surg</source><year>2022</year><volume>30</volume><issue>7</issue><fpage>313</fpage><lpage>320</lpage><pub-id pub-id-type="doi">10.5435/JAAOS-D-21-00703</pub-id><pub-id pub-id-type="pmid">35171881</pub-id></element-citation></ref><ref id="CR17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jennings</surname><given-names>JM</given-names></name><name name-style="western"><surname>Angerame</surname><given-names>MR</given-names></name><name name-style="western"><surname>Eschen</surname><given-names>CL</given-names></name><name name-style="western"><surname>Phocas</surname><given-names>AJ</given-names></name><name name-style="western"><surname>Dennis</surname><given-names>DA</given-names></name></person-group><article-title>Cannabis use does not affect outcomes after total knee arthroplasty</article-title><source>J Arthroplasty</source><year>2019</year><volume>34</volume><issue>8</issue><fpage>1667</fpage><lpage>1669</lpage><pub-id pub-id-type="doi">10.1016/j.arth.2019.04.015</pub-id><pub-id pub-id-type="pmid">31072746</pub-id></element-citation></ref><ref id="CR18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zalikha</surname><given-names>AK</given-names></name><name name-style="western"><surname>Rahmon</surname><given-names>D</given-names></name><name name-style="western"><surname>Mazur</surname><given-names>M</given-names></name><name name-style="western"><surname>Hussein</surname><given-names>IH</given-names></name><name name-style="western"><surname>El-Othmani</surname><given-names>MM</given-names></name></person-group><article-title>Cannabis use disorder in the setting of primary total hip arthroplasty: understanding the epidemiology, demographic characteristics, and inpatient postoperative outcomes</article-title><source>J Am Acad Orthop Surg</source><year>2022</year><volume>30</volume><issue>7</issue><fpage>321</fpage><lpage>328</lpage><pub-id pub-id-type="doi">10.5435/JAAOS-D-21-00976</pub-id><pub-id pub-id-type="pmid">35213453</pub-id></element-citation></ref><ref id="CR19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Copeland-Halperin</surname><given-names>LR</given-names></name><name name-style="western"><surname>Herrera-Gomez</surname><given-names>LC</given-names></name><name name-style="western"><surname>LaPier</surname><given-names>JR</given-names></name><name name-style="western"><surname>Shank</surname><given-names>N</given-names></name><name name-style="western"><surname>Shin</surname><given-names>JH</given-names></name></person-group><article-title>The effects of cannabis: implications for the surgical patient</article-title><source>Plast Reconstr Surg Glob Open</source><year>2021</year><volume>9</volume><issue>3</issue><fpage>e3448</fpage><pub-id pub-id-type="doi">10.1097/GOX.0000000000003448</pub-id><pub-id pub-id-type="pmid">33747688</pub-id><pub-id pub-id-type="pmcid">PMC7963514</pub-id></element-citation></ref><ref id="CR20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shah</surname><given-names>S</given-names></name><name name-style="western"><surname>Schwenk</surname><given-names>ES</given-names></name><name name-style="western"><surname>Sondekoppam</surname><given-names>RV</given-names></name><etal/></person-group><article-title>ASRA pain medicine consensus guidelines on the management of the perioperative patient on cannabis and cannabinoids</article-title><source>Reg Anesth Pain Med</source><year>2023</year><volume>48</volume><issue>3</issue><fpage>97</fpage><lpage>117</lpage><pub-id pub-id-type="doi">10.1136/rapm-2022-104013</pub-id><pub-id pub-id-type="pmid">36596580</pub-id></element-citation></ref><ref id="CR21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yang</surname><given-names>A</given-names></name><name name-style="western"><surname>Townsend</surname><given-names>CB</given-names></name><name name-style="western"><surname>Ilyas</surname><given-names>AM</given-names></name></person-group><article-title>Medical cannabis in hand surgery: a review of the current evidence</article-title><source>J Hand Surg Am</source><year>2023</year><volume>48</volume><issue>3</issue><fpage>292</fpage><lpage>300</lpage><pub-id pub-id-type="doi">10.1016/j.jhsa.2022.11.008</pub-id><pub-id pub-id-type="pmid">36609049</pub-id></element-citation></ref><ref id="CR22"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Whiting</surname><given-names>PF</given-names></name><name name-style="western"><surname>Wolff</surname><given-names>RF</given-names></name><name name-style="western"><surname>Deshpande</surname><given-names>S</given-names></name><etal/></person-group><article-title>Cannabinoids for medical use: a systematic review and meta-analysis</article-title><source>JAMA</source><year>2015</year><volume>313</volume><issue>24</issue><fpage>2456</fpage><pub-id pub-id-type="doi">10.1001/jama.2015.6358</pub-id><pub-id pub-id-type="pmid">26103030</pub-id></element-citation></ref><ref id="CR23"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>CW</given-names></name><name name-style="western"><surname>Bhatia</surname><given-names>A</given-names></name><name name-style="western"><surname>Buzon-Tan</surname><given-names>A</given-names></name><etal/></person-group><article-title>Weeding out the problem: the impact of preoperative cannabinoid use on pain in the perioperative period</article-title><source>Anesth Analg</source><year>2019</year><volume>129</volume><issue>3</issue><fpage>874</fpage><lpage>881</lpage><pub-id pub-id-type="doi">10.1213/ANE.0000000000003963</pub-id><pub-id pub-id-type="pmid">31425232</pub-id></element-citation></ref><ref id="CR24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Salottolo</surname><given-names>K</given-names></name><name name-style="western"><surname>Peck</surname><given-names>L</given-names></name><name name-style="western"><surname>Tanner</surname><given-names>A</given-names><suffix>II</suffix></name><etal/></person-group><article-title>The grass is not always greener: a multi-institutional pilot study of marijuana use and acute pain management following traumatic injury</article-title><source>Patient Saf Surg</source><year>2018</year><volume>12</volume><issue>1</issue><fpage>16</fpage><pub-id pub-id-type="doi">10.1186/s13037-018-0163-3</pub-id><pub-id pub-id-type="pmid">29946360</pub-id><pub-id pub-id-type="pmcid">PMC6007004</pub-id></element-citation></ref><ref id="CR25"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Aleissa</surname><given-names>MM</given-names></name><name name-style="western"><surname>Ahern</surname><given-names>KL</given-names></name><name name-style="western"><surname>Stern</surname><given-names>GM</given-names></name></person-group><article-title>Peri-operative opioid and sedation requirements in patients who use marijuana and are undergoing total knee or total hip arthroplasty: a retrospective study</article-title><source>J Clin Anesth</source><year>2020</year><volume>66</volume><fpage>109953</fpage><pub-id pub-id-type="doi">10.1016/j.jclinane.2020.109953</pub-id><pub-id pub-id-type="pmid">32619794</pub-id></element-citation></ref><ref id="CR26"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Khalid</surname><given-names>SI</given-names></name><name name-style="western"><surname>Jiang</surname><given-names>S</given-names></name><name name-style="western"><surname>Khilwani</surname><given-names>H</given-names></name><name name-style="western"><surname>Thomson</surname><given-names>K</given-names></name><name name-style="western"><surname>Mirpuri</surname><given-names>P</given-names></name><name name-style="western"><surname>Mehta</surname><given-names>AI</given-names></name></person-group><article-title>Postoperative opioid use among opioid-naive cannabis users following single-level lumbar fusions</article-title><source>World Neurosurg</source><year>2023</year><volume>175</volume><fpage>e644</fpage><lpage>e652</lpage><pub-id pub-id-type="doi">10.1016/j.wneu.2023.04.001</pub-id><pub-id pub-id-type="pmid">37030484</pub-id></element-citation></ref><ref id="CR27"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wiseman</surname><given-names>LK</given-names></name><name name-style="western"><surname>Mahu</surname><given-names>IT</given-names></name><name name-style="western"><surname>Mukhida</surname><given-names>K</given-names></name></person-group><article-title>The effect of preoperative cannabis use on postoperative pain following gynaecologic oncology surgery</article-title><source>J Obstet Gynaecol Can</source><year>2022</year><volume>44</volume><issue>7</issue><fpage>750</fpage><lpage>756</lpage><pub-id pub-id-type="doi">10.1016/j.jogc.2022.01.018</pub-id><pub-id pub-id-type="pmid">35202866</pub-id></element-citation></ref><ref id="CR28"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jamal</surname><given-names>N</given-names></name><name name-style="western"><surname>Korman</surname><given-names>J</given-names></name><name name-style="western"><surname>Musing</surname><given-names>M</given-names></name><etal/></person-group><article-title>Effects of pre-operative recreational smoked cannabis use on opioid consumption following inflammatory bowel disease surgery: a historical cohort study</article-title><source>Eur J Anaesthesiol</source><year>2019</year><volume>36</volume><issue>9</issue><fpage>705</fpage><lpage>706</lpage><pub-id pub-id-type="doi">10.1097/EJA.0000000000001044</pub-id><pub-id pub-id-type="pmid">31365416</pub-id></element-citation></ref><ref id="CR29"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bonnet</surname><given-names>U</given-names></name><name name-style="western"><surname>Preuss</surname><given-names>U</given-names></name></person-group><article-title>The cannabis withdrawal syndrome: current insights</article-title><source>SAR</source><year>2017</year><volume>8</volume><fpage>9</fpage><lpage>37</lpage><pub-id pub-id-type="doi">10.2147/SAR.S109576</pub-id><pub-id pub-id-type="pmcid">PMC5414724</pub-id><pub-id pub-id-type="pmid">28490916</pub-id></element-citation></ref><ref id="CR30"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Stewart</surname><given-names>C</given-names></name><name name-style="western"><surname>Fong</surname><given-names>Y</given-names></name></person-group><article-title>Perioperative cannabis as a potential solution for reducing opioid and benzodiazepine dependence</article-title><source>JAMA Surg</source><year>2021</year><volume>156</volume><issue>2</issue><fpage>181</fpage><lpage>190</lpage><pub-id pub-id-type="doi">10.1001/jamasurg.2020.5545</pub-id><pub-id pub-id-type="pmid">33263719</pub-id></element-citation></ref><ref id="CR31"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Buggy</surname><given-names>DJ</given-names></name><name name-style="western"><surname>Toogood</surname><given-names>L</given-names></name><name name-style="western"><surname>Maric</surname><given-names>S</given-names></name><name name-style="western"><surname>Sharpe</surname><given-names>P</given-names></name><name name-style="western"><surname>Lambert</surname><given-names>DG</given-names></name><name name-style="western"><surname>Rowbotham</surname><given-names>DJ</given-names></name></person-group><article-title>Lack of analgesic efficacy of oral &#948;-9-tetrahydrocannabinol in postoperative pain</article-title><source>Pain</source><year>2003</year><volume>106</volume><issue>1</issue><fpage>169</fpage><lpage>172</lpage><pub-id pub-id-type="doi">10.1016/S0304-3959(03)00331-2</pub-id><pub-id pub-id-type="pmid">14581124</pub-id></element-citation></ref><ref id="CR32"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Holdcroft</surname><given-names>A</given-names></name><name name-style="western"><surname>Maze</surname><given-names>M</given-names></name><name name-style="western"><surname>Dor&#233;</surname><given-names>C</given-names></name><name name-style="western"><surname>Tebbs</surname><given-names>S</given-names></name><name name-style="western"><surname>Thompson</surname><given-names>S</given-names></name></person-group><article-title>A multicenter dose-escalation study of the analgesic and adverse effects of an oral cannabis extract (cannador) for postoperative pain management</article-title><source>Anesthesiology</source><year>2006</year><volume>104</volume><issue>5</issue><fpage>1040</fpage><lpage>1046</lpage><pub-id pub-id-type="doi">10.1097/00000542-200605000-00021</pub-id><pub-id pub-id-type="pmid">16645457</pub-id></element-citation></ref><ref id="CR33"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jain</surname><given-names>AK</given-names></name><name name-style="western"><surname>Ryan</surname><given-names>JR</given-names></name><name name-style="western"><surname>McMahon</surname><given-names>FG</given-names></name><name name-style="western"><surname>Smith</surname><given-names>G</given-names></name></person-group><article-title>Evaluation of intramuscular levonantradol and placebo in acute postoperative pain</article-title><source>J Clin Pharmaol</source><year>1981</year><volume>21</volume><issue>S1</issue><fpage>320S</fpage><lpage>326S</lpage><pub-id pub-id-type="doi">10.1002/j.1552-4604.1981.tb02610.x</pub-id><pub-id pub-id-type="pmid">7028791</pub-id></element-citation></ref><ref id="CR34"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>McAfee</surname><given-names>J</given-names></name><name name-style="western"><surname>Boehnke</surname><given-names>KF</given-names></name><name name-style="western"><surname>Moser</surname><given-names>SM</given-names></name><name name-style="western"><surname>Brummett</surname><given-names>CM</given-names></name><name name-style="western"><surname>Waljee</surname><given-names>JF</given-names></name><name name-style="western"><surname>Bonar</surname><given-names>EE</given-names></name></person-group><article-title>Perioperative cannabis use: a longitudinal study of associated clinical characteristics and surgical outcomes</article-title><source>Reg Anesth Pain Med</source><year>2021</year><volume>46</volume><issue>2</issue><fpage>137</fpage><lpage>144</lpage><pub-id pub-id-type="doi">10.1136/rapm-2020-101812</pub-id><pub-id pub-id-type="pmid">33208521</pub-id><pub-id pub-id-type="pmcid">PMC8284917</pub-id></element-citation></ref><ref id="CR35"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Albelo</surname><given-names>FD</given-names></name><name name-style="western"><surname>Baker</surname><given-names>M</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>T</given-names></name><etal/></person-group><article-title>Impact of pre-operative recreational marijuana use on outcomes two years after orthopaedic surgery</article-title><source>Int Orthop</source><year>2021</year><volume>45</volume><issue>10</issue><fpage>2483</fpage><lpage>2490</lpage><pub-id pub-id-type="doi">10.1007/s00264-021-05069-3</pub-id><pub-id pub-id-type="pmid">34052856</pub-id></element-citation></ref><ref id="CR36"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Van Boekel</surname><given-names>LC</given-names></name><name name-style="western"><surname>Brouwers</surname><given-names>EPM</given-names></name><name name-style="western"><surname>Van Weeghel</surname><given-names>J</given-names></name><name name-style="western"><surname>Garretsen</surname><given-names>HFL</given-names></name></person-group><article-title>Stigma among health professionals towards patients with substance use disorders and its consequences for healthcare delivery: systematic review</article-title><source>Drug Alcohol Depend</source><year>2013</year><volume>131</volume><issue>1&#8211;2</issue><fpage>23</fpage><lpage>35</lpage><pub-id pub-id-type="doi">10.1016/j.drugalcdep.2013.02.018</pub-id><pub-id pub-id-type="pmid">23490450</pub-id></element-citation></ref><ref id="CR37"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Suhre</surname><given-names>W</given-names></name><name name-style="western"><surname>O&#8217;Reilly-Shah</surname><given-names>V</given-names></name><name name-style="western"><surname>Van Cleve</surname><given-names>W</given-names></name></person-group><article-title>Cannabis use is associated with a small increase in the risk of postoperative nausea and vomiting: a retrospective machine-learning causal analysis</article-title><source>BMC Anesthesiol</source><year>2020</year><volume>20</volume><issue>1</issue><fpage>115</fpage><pub-id pub-id-type="doi">10.1186/s12871-020-01036-4</pub-id><pub-id pub-id-type="pmid">32423445</pub-id><pub-id pub-id-type="pmcid">PMC7236204</pub-id></element-citation></ref><ref id="CR38"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Echeverria-Villalobos</surname><given-names>M</given-names></name><name name-style="western"><surname>Todeschini</surname><given-names>AB</given-names></name><name name-style="western"><surname>Stoicea</surname><given-names>N</given-names></name><name name-style="western"><surname>Fiorda-Diaz</surname><given-names>J</given-names></name><name name-style="western"><surname>Weaver</surname><given-names>T</given-names></name><name name-style="western"><surname>Bergese</surname><given-names>SD</given-names></name></person-group><article-title>Perioperative care of cannabis users: a comprehensive review of pharmacological and anesthetic considerations</article-title><source>J Clin Anesth</source><year>2019</year><volume>57</volume><fpage>41</fpage><lpage>49</lpage><pub-id pub-id-type="doi">10.1016/j.jclinane.2019.03.011</pub-id><pub-id pub-id-type="pmid">30852326</pub-id></element-citation></ref><ref id="CR39"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Goel</surname><given-names>A</given-names></name><name name-style="western"><surname>McGuinness</surname><given-names>B</given-names></name><name name-style="western"><surname>Jivraj</surname><given-names>NK</given-names></name><etal/></person-group><article-title>Cannabis use disorder and perioperative outcomes in major elective surgeries</article-title><source>Anesthesiology</source><year>2020</year><volume>132</volume><issue>4</issue><fpage>625</fpage><lpage>635</lpage><pub-id pub-id-type="doi">10.1097/ALN.0000000000003067</pub-id><pub-id pub-id-type="pmid">31789638</pub-id></element-citation></ref><ref id="CR40"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Huson</surname><given-names>HB</given-names></name><name name-style="western"><surname>Granados</surname><given-names>TM</given-names></name><name name-style="western"><surname>Rasko</surname><given-names>Y</given-names></name></person-group><article-title>Surgical considerations of marijuana use in elective procedures</article-title><source>Heliyon</source><year>2018</year><volume>4</volume><issue>9</issue><fpage>e00779</fpage><pub-id pub-id-type="doi">10.1016/j.heliyon.2018.e00779</pub-id><pub-id pub-id-type="pmid">30225378</pub-id><pub-id pub-id-type="pmcid">PMC6139487</pub-id></element-citation></ref><ref id="CR41"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Potnuru</surname><given-names>PP</given-names></name><name name-style="western"><surname>Jonna</surname><given-names>S</given-names></name><name name-style="western"><surname>Williams</surname><given-names>GW</given-names></name></person-group><article-title>Cannabis use disorder and perioperative complications</article-title><source>JAMA Surg</source><year>2023</year><volume>158</volume><issue>9</issue><fpage>935</fpage><lpage>944</lpage><pub-id pub-id-type="doi">10.1001/jamasurg.2023.2403</pub-id><pub-id pub-id-type="pmid">37405729</pub-id><pub-id pub-id-type="pmcid">PMC10323761</pub-id></element-citation></ref><ref id="CR42"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chiu</surname><given-names>RG</given-names></name><name name-style="western"><surname>Patel</surname><given-names>S</given-names></name><name name-style="western"><surname>Siddiqui</surname><given-names>N</given-names></name><name name-style="western"><surname>Nunna</surname><given-names>RS</given-names></name><name name-style="western"><surname>Mehta</surname><given-names>AI</given-names></name></person-group><article-title>Cannabis abuse and perioperative complications following inpatient spine surgery in the United States</article-title><source>Spine</source><year>2021</year><volume>46</volume><issue>11</issue><fpage>734</fpage><lpage>743</lpage><pub-id pub-id-type="doi">10.1097/BRS.0000000000004035</pub-id><pub-id pub-id-type="pmid">33769411</pub-id></element-citation></ref><ref id="CR43"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>McGuinness</surname><given-names>B</given-names></name><name name-style="western"><surname>Goel</surname><given-names>A</given-names></name><name name-style="western"><surname>Elias</surname><given-names>F</given-names></name><name name-style="western"><surname>Rapanos</surname><given-names>T</given-names></name><name name-style="western"><surname>Mittleman</surname><given-names>MA</given-names></name><name name-style="western"><surname>Ladha</surname><given-names>KS</given-names></name></person-group><article-title>Cannabis use disorder and perioperative outcomes in vascular surgery</article-title><source>J Vasc Surg</source><year>2021</year><volume>73</volume><issue>4</issue><fpage>1376</fpage><lpage>1387.e3</lpage><pub-id pub-id-type="doi">10.1016/j.jvs.2020.07.094</pub-id><pub-id pub-id-type="pmid">32861869</pub-id></element-citation></ref><ref id="CR44"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shah</surname><given-names>RM</given-names></name><name name-style="western"><surname>Patel</surname><given-names>S</given-names></name><name name-style="western"><surname>Patel</surname><given-names>S</given-names></name><name name-style="western"><surname>Sandhu</surname><given-names>LK</given-names></name><name name-style="western"><surname>Chand</surname><given-names>B</given-names></name></person-group><article-title>Severe cannabis use is associated with complications and prolonged length of stay in bariatric surgery</article-title><source>Obes Surg</source><year>2023</year><volume>33</volume><issue>5</issue><fpage>1333</fpage><lpage>1337</lpage><pub-id pub-id-type="doi">10.1007/s11695-023-06552-z</pub-id><pub-id pub-id-type="pmid">36929346</pub-id></element-citation></ref><ref id="CR45"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vakharia</surname><given-names>RM</given-names></name><name name-style="western"><surname>Sodhi</surname><given-names>N</given-names></name><name name-style="western"><surname>Anis</surname><given-names>HK</given-names></name><name name-style="western"><surname>Ehiorobo</surname><given-names>JO</given-names></name><name name-style="western"><surname>Mont</surname><given-names>MA</given-names></name><name name-style="western"><surname>Roche</surname><given-names>MW</given-names></name></person-group><article-title>Patients who have cannabis use disorder have higher rates of venous thromboemboli, readmission rates, and costs following primary total knee arthroplasty</article-title><source>J Arthroplasty</source><year>2020</year><volume>35</volume><issue>4</issue><fpage>997</fpage><lpage>1002</lpage><pub-id pub-id-type="doi">10.1016/j.arth.2019.11.035</pub-id><pub-id pub-id-type="pmid">31973970</pub-id></element-citation></ref><ref id="CR46"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bauer</surname><given-names>FL</given-names></name><name name-style="western"><surname>Donahoo</surname><given-names>WT</given-names></name><name name-style="western"><surname>Hollis</surname><given-names>HW</given-names></name><etal/></person-group><article-title>Marijuana&#8217;s influence on pain scores, initial weight loss, and other bariatric surgical outcomes</article-title><source>Perm J</source><year>2018</year><volume>22</volume><fpage>18</fpage><lpage>002</lpage><pub-id pub-id-type="doi">10.7812/TPP/18-002</pub-id><pub-id pub-id-type="pmid">30010532</pub-id><pub-id pub-id-type="pmcid">PMC6047845</pub-id></element-citation></ref><ref id="CR47"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jung</surname><given-names>F</given-names></name><name name-style="western"><surname>Lee</surname><given-names>Y</given-names></name><name name-style="western"><surname>Manzoor</surname><given-names>S</given-names></name><name name-style="western"><surname>Hong</surname><given-names>D</given-names></name><name name-style="western"><surname>Doumouras</surname><given-names>AG</given-names></name></person-group><article-title>Effects of perioperative cannabis use on bariatric surgical outcomes: a systematic review</article-title><source>Obes Surg</source><year>2021</year><volume>31</volume><issue>1</issue><fpage>299</fpage><lpage>306</lpage><pub-id pub-id-type="doi">10.1007/s11695-020-04962-x</pub-id><pub-id pub-id-type="pmid">32970257</pub-id></element-citation></ref><ref id="CR48"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shockcor</surname><given-names>N</given-names></name><name name-style="western"><surname>Adnan</surname><given-names>SM</given-names></name><name name-style="western"><surname>Siegel</surname><given-names>A</given-names></name><name name-style="western"><surname>Wise</surname><given-names>E</given-names></name><name name-style="western"><surname>Zafar</surname><given-names>SN</given-names></name><name name-style="western"><surname>Kligman</surname><given-names>M</given-names></name></person-group><article-title>Marijuana use does not affect the outcomes of bariatric surgery</article-title><source>Surg Endosc</source><year>2021</year><volume>35</volume><issue>3</issue><fpage>1264</fpage><lpage>1268</lpage><pub-id pub-id-type="doi">10.1007/s00464-020-07497-5</pub-id><pub-id pub-id-type="pmid">32166550</pub-id></element-citation></ref><ref id="CR49"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>BH</given-names></name><name name-style="western"><surname>Saud</surname><given-names>H</given-names></name><name name-style="western"><surname>Sengupta</surname><given-names>N</given-names></name><etal/></person-group><article-title>Effect of preoperative cannabis use on perioperative outcomes: a retrospective cohort study</article-title><source>Reg Anesth Pain Med</source><year>2021</year><volume>46</volume><issue>8</issue><fpage>650</fpage><lpage>655</lpage><pub-id pub-id-type="doi">10.1136/rapm-2021-102479</pub-id><pub-id pub-id-type="pmid">33990440</pub-id></element-citation></ref><ref id="CR50"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Worrest</surname><given-names>T</given-names></name><name name-style="western"><surname>Malibiran</surname><given-names>CC</given-names></name><name name-style="western"><surname>Welshans</surname><given-names>J</given-names></name><name name-style="western"><surname>Dewey</surname><given-names>E</given-names></name><name name-style="western"><surname>Husain</surname><given-names>F</given-names></name></person-group><article-title>Marijuana use does not affect weight loss or complication rate after bariatric surgery</article-title><source>Surg Endosc</source><year>2022</year><volume>36</volume><issue>9</issue><fpage>6931</fpage><lpage>6936</lpage><pub-id pub-id-type="doi">10.1007/s00464-022-09038-8</pub-id><pub-id pub-id-type="pmid">35024935</pub-id></element-citation></ref></ref-list></back></article></pmc-articleset>